ArticleFrontiers in oncology2026

ATRX large deletions and truncating mutations are associated with primary induction chemotherapy resistance in high-risk neuroblastoma: a multicenter propensity-weighted cohort study.

Jing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.